Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decline in short interest in the month of May. As of May 29th, there was short interest totaling 69 shares, a decline of 90.6% from the May 14th total of 734 shares. Based on an average daily trading volume, of 2,285 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

Several hedge funds have recently bought and sold shares of the company. Susquehanna International Group LLP lifted its position in Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares during the last quarter. Comprehensive Wealth Management LLC lifted its position in Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the last quarter. Finally, Osaic Holdings Inc. lifted its position in Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Stock Performance

Shares of NYSEARCA BOUT traded up $1.63 during midday trading on Thursday, hitting $46.75. The company’s stock had a trading volume of 529 shares, compared to its average volume of 4,498. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $48.05. The firm’s fifty day moving average price is $44.70 and its 200-day moving average price is $40.71. The firm has a market cap of $16.36 million, a P/E ratio of 28.69 and a beta of 1.04.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.